Clinical Trials Logo

Filter by:
NCT ID: NCT01283737 Withdrawn - Clinical trials for Osteochondritis Dissecans

Use of Demineralised Bone Matrix (DBX) in Osteochondritis Dissecans (OCD)

Start date: n/a
Phase: Phase 4
Study type: Interventional

This is a 1:1 randomised pilot study in 30 patients in 1 site in Helsinki, Finland. The investigators hypothesize that function, pain, type and quality of cartilage in adult patients with osteochondritis dissecans of the knee will be better in the DBX group compared to the mosaicplasty group.

NCT ID: NCT01288625 Withdrawn - Oral Mucositis Clinical Trials

Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine

Start date: n/a
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.

NCT ID: NCT01295073 Withdrawn - Clinical trials for Macular Edema Following Cataract Surgery

Trientine Hydrochloride for the Prevention of Macular Edema After Cataract Surgery in Patients With Type 2 Diabetes Mellitus

Start date: n/a
Phase: Phase 2
Study type: Interventional

The primary purpose of the protocol is to evaluate whether Trientine Hydrochloride, a copper chelator which is an agent that binds with and removes copper, will be effective in minimizing macular edema after cataract surgery in individuals with type 2 diabetes. It is our hypothesis that there will be a reduction in copper-attributed inflammation after surgery resulting a decrease in edema.

NCT ID: NCT01295099 Withdrawn - Keloid Scar Clinical Trials

Keloid Scarring: Treatment and Pathophysiology

Start date: n/a
Phase: Phase 4
Study type: Interventional

To clarify the mechanisms of Keloid scar formation. Elucidate the action and therapeutic value of 5-FU in Keloid scar treatment Identify the genetic link with Keloid scar formation. Quantify the psychological/social impact in keloid scarring patients

NCT ID: NCT01300091 Withdrawn - Shoulder Pain Clinical Trials

Burden and Outcome of Shoulder Disorders in Primary Health Care

Start date: n/a
Phase:
Study type: Observational

Consumption of medical care and outcome of shoulder pain and disability in primary care.

NCT ID: NCT01302106 Withdrawn - Clinical trials for Myelodysplastic Syndromes

Study of Clofarabine in Combination With Low Dose Cytarabine to Treat Myelodysplastic Syndromes

CLO2009AISSM05
Start date: n/a
Phase: Phase 2
Study type: Interventional

This is an interventional, multicenter, open label, phase II study designed to evaluate the safety and efficacy of Clofarabine in combination with low dose Cytarabine in untreated patients with poor risk of Myelodisplastic Syndromes.

NCT ID: NCT01303107 Withdrawn - Cesarean Delivery Clinical Trials

Comparative Mixture of Non-racemic and Racemic Enantiomers of Bupivacaine in Cesarean

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the mixture of enantiomers of bupivacaine (bupivacaine S75:R25) dos not represent inferiority efficacy and safety compare to the racemic mixture of enantiomers of bupivacaine (bupivacaine S50:R50).

NCT ID: NCT01304628 Withdrawn - Asthma Clinical Trials

Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma

Start date: n/a
Phase: Phase 2
Study type: Interventional

The objective of this study is to evaluate if single subcutaneous (SC) doses of PL-3994, administered to patients with asthma can achieve a clinically meaningful increase in pulmonary function (Forced Expiratory Volume in one second: FEV1) while maintaining an acceptable safety profile. The study will characterize the bronchodilator effect, dose and safety of PL-3994 in a population of moderately severe, stable asthmatics following overnight withdrawal of beta-2 agonists.

NCT ID: NCT01308047 Withdrawn - Clinical trials for Fracture of Lower Limb

Comparing Heavy Levobupivacaine With Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine.

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the non-inferiority between Heavy Levobupivacaine with Enantiomeric Excess of 50% and Heavy Racemic Bupivacaine During Spinal Anesthesia for Orthopedic Procedures in the Lower Limbs.

NCT ID: NCT01311414 Withdrawn - Cerebral Ischemia Clinical Trials

Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation

NIRSMED
Start date: n/a
Phase: N/A
Study type: Interventional

During clamping of one internal carotid artery for endarterectomy, blood flow through this vessel has to be compensated by collateral arteries including the contralateral internal artery and vertebral arteries. In 7 % of all patients undergoing carotid endarterectomy this collateral flow is not sufficient to maintain adequate cerebral perfusion during clamping and ischemic brain damage is likely to emerge. To maximize cerebral blood flow during clamping, increase of blood pressure is a common procedure and routine at our institution. Increasing blood pressure can be enabled by tapering a mixture of Cafedrine und Theodrenalin (Akrinor®) until the designated blood pressure is reached. After declamping, the blood pressure has to be reduced to normal values to avoid postoperative hyperperfusion syndrome. This is enabled by tapering urapidil until normal blood pressure is achieved. It has been shown that cerebral oxygenation measured by near infrared spectroscopy is reduced by intravenous application of norepinephrine. Otherwise, intravenous nitroglycerine increases cerebral oxygenation during cardiopulmonary bypass. Hence, cafedrine/theodrenalin and urapidil may also have an effect on cerebral perfusion. In this prospective randomized study the effect of cafedrine/theodrenalin and urapidil on cerebral oxygenation measured by near infrared spectroscopy is investigated.